Vanflyta (Quizartinib)

Vanflyta (Quizartinib) is a kinase inhibitor used in conjunction with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following consolidation chemotherapy, to treat adults with newly diagnosed AML (acute myeloid leukemia) that is FLT3-ITD-positive.

Recommended Dosage: The recommended dose of Vanflyta tablet is administered orally with or without food at around the same time each day. Swallow tablets whole. Do not crush, cut, or chew them. The recommended dose is as follows:

• Induction: 35.4 mg taken orally once daily on Days 8 to 21 of “7 + 3” (cytarabine [100 or 200 mg/m2 per day] on Days 1 to 7 plus daunorubicin [60 mg/m2 per day] or idarubicin [12 mg/m2 per day] on Days 1 to 3) and on Days 8-21 or 6-19 of an optional second induction (“7 + 3” or “5 + 2” [5 days cytarabine plus 2 days idarubicin or daunorubicin], respectively),
• Consolidation: 35.4 mg taken orally once daily on Days 6 to 19 of high‑dose cytarabine (1.5 to 3 g/m2 every 12 hours on Days 1, 3 & 5) for up to 4 cycles, and
• Maintenance: 26.5 mg taken orally once daily on Days 1 to 14 and 53 mg once daily, thereafter, for up to thirty-six 28-day cycles.

• Vanflyta (Quizartinib) is a kinase inhibitor used in conjunction with standard cytarabine and anthracycline induction and cytarabine consolidation, and as maintenance monotherapy following consolidation chemotherapy, to treat adults with newly diagnosed AML (acute myeloid leukemia) that is FLT3-ITD-positive.
• Recommended Dosage: The recommended dose of Vanflyta tablet is administered orally with or without food at around the same time each day. Swallow tablets whole. Do not crush, cut, or chew them. The recommended dose is as follows:
  
• Induction: 35.4 mg taken orally once daily on Days 8 to 21 of “7 + 3” (cytarabine [100 or 200 mg/m2 per day] on Days 1 to 7 plus daunorubicin [60 mg/m2 per day] or idarubicin [12 mg/m2 per day] on Days 1 to 3) and on Days 8-21 or 6-19 of an optional second induction (“7 + 3” or “5 + 2” [5 days cytarabine plus 2 days idarubicin or daunorubicin], respectively),
  
• Consolidation: 35.4 mg taken orally once daily on Days 6 to 19 of high‑dose cytarabine (1.5 to 3 g/m2 every 12 hours on Days 1, 3 & 5) for up to 4 cycles, and
  
• Maintenance: 26.5 mg taken orally once daily on Days 1 to 14 and 53 mg once daily, thereafter, for up to thirty-six 28-day cycles.
• If a dose is vomited, do not take a replacement dose; wait until the very next scheduled dose is due. If a dose is missed or not taken at the usual time, administer the dose as quickly as possible on the same day and return to the usual schedule the following day. The patient must not take a couple of doses on the same day. 

What documents are required to import VANFLYTA® to India?

VANFLYTA® (quizartinib) tablets can be imported by patients or government hospitals on the name of the patients only. 

The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
  
• Patients diagnostic reports
  
• Patients id proof (issued by the government of India)

How does the order be confirmed?

• The order will be confirmed only after the receipt of:
  
• A valid prescription from Doctor
  
• Import permit if applicable

Is VANFLYTA® available in India?

VANFLYTA® (quizartinib tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input

• On availability of Vanflyta in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
  
• Medicine Price.
  
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
  
• Ensuring 100% transparency.

VANFLYTA® can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of VANFLYTA® (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)

Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Vanflyta price in India. 

We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network is able to source the VANFLYTA® (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Vanflyta®?

Quizartinib is a Generic Name for the trade name drug Vanflyta®.

What is the Manufacturer’s Name of Vanflyta®?

Vanflyta® is manufactured by Daiichi Sankyo, Inc.

Is Vanflyta® approved by the FDA?

Yes, Vanflyta® is approved by the FDA. Date of approval: July 20, 2023.

What is the dosage and form of Vanflyta® supplied?

Vanflyta® is supplied as Tablets: 17.7 mg or 26.5 mg for oral administration. 

What are the most common side effects of Vanflyta®? 

The most common side effects of Vanflyta® are diarrhea, calcium decreased, mucositis, abdominal pain, upper respiratory tract infection, sepsis, nausea, neutropenia, vomiting, and headache.

How much does Vanflyta® cost in India?

The cost of Vanflyta in India can vary. In order to procure this AML medication legally, you can Call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.

What are the storage conditions of Vanflyta®?

Store the film-coated tablets of Vanflyta® at 20 to 25°C (68 to 77°F); excursions permitted from 15-30°C (59-86°F).

Is it safe to buy Vanflyta® online in India?

Yes, one can buy Vanflyta online in India at the lowest price from the Indian Pharma Network (IPN) if the medicine Vanflyta® is not (yet) registered or is available in your country. We can help facilitate the supply of Vanflyta® through legal channels.